Pharmacological treatment of anxiety disorders: current treatments and future directions - Test2 - elhamkhani - TriplyDB

Pharmacological treatment of anxiety disorders: current treatments and future directions

Pharmacological treatment of anxiety disorders: current treatments and future directions

http://www.wikidata.org/entity/Q26851461

about

Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review SCOP/PHLPP1β in the basolateral amygdala regulates circadian expression of mouse anxiety-like behavior.Posttraumatic Stress Disorder: Overview of Evidence-Based Assessment and Treatment The POSE study - panic control treatment versus panic-focused psychodynamic psychotherapy under randomized and self-selection conditions: study protocol for a randomized controlled trial.Hypothalamic-pituitary-adrenocortical axis: neuropsychiatric aspects.Novel investigational therapeutics for panic disorder.Strategies included in cognitive behavioral therapy programs to treat internalized disorders: a systematic review.Modulation of naturalistic maladaptive memories using behavioural and pharmacological reconsolidation-interfering strategies: a systematic review and meta-analysis of clinical and 'sub-clinical' studies

P2860

Q22305514-666963A4-ABE9-4DDC-8B18-263C97BB438B Q27347885-B43BC306-A609-4E9D-BC03-AFE7B4655F2E Q28078814-4AC18EAF-635C-4298-9C4D-BDC08B43ED50 Q35368121-E4239976-1668-4EF6-A2CD-6AF5FB92900C Q38203227-83C43E07-22E2-46FF-8743-8F07BC4C06EE Q38300166-DD4BB46E-7D1A-4BC7-AFE7-59AD2C563A6D Q47719041-8CC7659A-22A9-4992-95EF-276F85DDDE84 Q58794914-B36C0D90-817E-455B-8B75-6A471CD90737

P2860

Pharmacological treatment of anxiety disorders: current treatments and future directions

http://www.wikidata.org/entity/Q26851461

description

2012 nî lūn-bûn

@nan

2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Pharmacological treatment of anxiety disorders: current treatments and future directions

@ast

Pharmacological treatment of anxiety disorders: current treatments and future directions

@en

Pharmacological treatment of anxiety disorders: current treatments and future directions

@nl

type

label

Pharmacological treatment of anxiety disorders: current treatments and future directions

@ast

Pharmacological treatment of anxiety disorders: current treatments and future directions

@en

Pharmacological treatment of anxiety disorders: current treatments and future directions

@nl

prefLabel

Pharmacological treatment of anxiety disorders: current treatments and future directions

@ast

Pharmacological treatment of anxiety disorders: current treatments and future directions

@en

Pharmacological treatment of anxiety disorders: current treatments and future directions

@nl

P1433

Q26851461-4DC60A32-4071-4BED-AF1B-7AB0344776B4

P1476

Q26851461-04C3C0D8-942B-4C7A-B627-6E11800F7DB0

P2093

Q26851461-743DD175-7C3F-4D29-A014-51907BFEF61A

Q26851461-AC250C71-85D3-473C-AD3E-6822B07D4E23

Q26851461-BAF29D5C-A217-4985-A97F-C9713FC707BD

Q26851461-FAFD7CF2-8C6A-4B03-B922-50C6CBB4EACA

P2860

Q26851461-00BFD05B-23C3-4A67-A8C8-D101B991685C

Q26851461-01D794ED-C674-4BAA-9DCD-7EF3CDDEE16A

Q26851461-04D0708E-99AE-4EF8-89EF-E2C11CBAACF6

Q26851461-0530D252-A761-40C0-B88B-5EC0FB23DCCB

Q26851461-0752183D-8A47-4055-AF12-A6A1116BD06B

Q26851461-093A6B6A-0D0F-44A2-97AB-43243DD4D6AC

Q26851461-0A67B59C-5FE5-4B65-9A82-D60D712A4B59

Q26851461-0B51B176-9409-48EC-8775-21AA32966BFA

Q26851461-0E65A7ED-4448-4F91-AE46-4D09FA684018

Q26851461-0ED3F5B7-5395-4EB9-974F-2EF1AC6C49BB

P304

Q26851461-F02502C3-6ED6-4FA7-AE7E-158C78F07800

P31

Q26851461-43C6A776-7139-469F-BE17-C1BC46EBC1EF

P3181

Q26851461-7386482F-A06D-4A00-B74D-D6B84748035E

P356

Q26851461-38AA211D-423E-4D32-8563-8F4D6340F552

P407

Q26851461-341DE000-7F46-4AB9-89EE-27107DD1EFC9

P433

Q26851461-661002F3-ADBE-4217-A98D-3E7A00BE1FA3

P478

Q26851461-6E41272D-7892-447D-8984-B5311326AB02

P50

Q26851461-44D2580A-71B8-42AA-A393-538F0624D52A

Q26851461-8D015C3D-D72D-42AF-9B57-5BA5F0980785

P577

Q26851461-BD19324E-F922-4159-993B-47342A7F05BF

P5875

Q26851461-68B2919E-16EC-4BEF-8CA4-C12F92DF89FF

P698

Q26851461-059E3E83-011A-42D1-B7C7-7299C02CC93A

P921

Q26851461-8589DC88-C08E-454D-B0E1-B7D0DA9B69B9

P932

Q26851461-99D4EA53-D489-4842-8486-0104B7604880

P3181

P356

J.JANXDIS.2012.07.009

P1433

Journal of Anxiety Disorders

P1476

Pharmacological treatment of anxiety disorders: current treatments and future directions

@en

P2093

Alissa B Jerud

http://www.w3.org/2001/XMLSchema#string

Janie J Jun

http://www.w3.org/2001/XMLSchema#string

Lori A Zoellner

http://www.w3.org/2001/XMLSchema#string

Peter P Roy-Byrne

http://www.w3.org/2001/XMLSchema#string

P2860

The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

Second-generation antipsychotics for anxiety disorders

Second-generation antipsychotics for obsessive compulsive disorder

Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders

Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.

Antidepressant drug effects and depression severity: a patient-level meta-analysis

Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine

Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients

An emotion-induced retrograde amnesia in humans is amygdala- and beta-adrenergic-dependent

The molecular neurobiology of depression

P304

833-843

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3473559

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.JANXDIS.2012.07.009

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231612865

http://www.w3.org/2001/XMLSchema#string

P698

23023162

http://www.w3.org/2001/XMLSchema#string

P921

P932

3539724

http://www.w3.org/2001/XMLSchema#string